What happens when scientists set out to prove something is deadly, but instead discover the fountain of youth? That's exactly what occurred in 2012 when researchers in Paris tested a Nobel Prize-winning molecule called C60 — and the results have sent shockwaves through the scientific community while being largely ignored by mainstream medicine.
The landmark Baati study, published in the peer-reviewed journal Biomaterials, was supposed to demonstrate the toxicity of this carbon molecule. Instead, it revealed three extraordinary breakthroughs that could revolutionize human health: the treated group lived 90 percent longer than controls, aged without detectable tumors, and showed remarkable resistance to liver toxins that destroyed untreated subjects.
In an exclusive interview on Next News Network, host Gary Franchi spoke with Chris Burres and Patty Greer from C60 Evo, who have been at the forefront of this revolutionary discovery. Burres has been manufacturing this molecule since 1991 — five years before the Nobel Prize was even awarded for fullerenes in 1996.
"His doctor told him whatever you are doing, keep doing it,"
Burres revealed his own shocking biological age test results that left doctors speechless. While his chronological age puts him in his 50s, the ESR test showed a biological age over 20 years younger. Even more remarkable, the GlycanAge test came back showing a biological age of just 21 — a stunning 34 years younger than his actual age.
The Three-Month Transformation
Users report a predictable journey of improvement. Month one brings enhanced energy and mental focus. Month two delivers deeper sleep and improved circadian rhythms. By month three, users unlock endurance and vitality that fundamentally changes how they move through daily life.
Patty Greer shared her own remarkable recovery story, crediting the molecule with saving her life after surviving uranium poisoning — a testament to its powerful detoxification properties.
Franchi himself has become a believer after months of daily use. His wife Angie, who suffered from debilitating migraines, hasn't had one since starting the regimen. "His energy and focus have been transformed," making it an essential part of his daily health toolkit.
With Big Pharma profits threatened by a simple molecule that could extend healthy lifespan, how long before this breakthrough faces regulatory assault? The question isn't whether this technology works — the peer-reviewed science speaks for itself — but whether Americans will have access to it.